Renal fibrosis: Insight from proteomics in animal models and human disease

Proteomics

Volumn 11, Issue 4, 2011, Pages 805-815

  Klein, Julie ^a,b   Kavvadas, Panagiotis ^c   Prakoura, Niki ^c   Karagianni, Fani ^c   Schanstra, Joost P ^a,b   Bascands, Jean Loup ^a,b   Charonis, Aristidis ^c  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Animal proteomics; Chronic kidney disease; Fibrosis

Indexed keywords

BIOLOGICAL MARKER;

BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY CELL; KIDNEY FAILURE; KIDNEY FIBROSIS; MESANGIUM CELL; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEOMICS; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; PROTEOMICS;

ANIMALIA;

EID: 79551476947     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000380     Document Type: Review

References (46)

1. de Jong, P. E., van der Velde, M., Gansevoort, R. T., Zoccali, C., Screening for chronic kidney disease: where does Europe go? Clin. J. Am. Soc. Nephrol. 2008, 3, 616-623.
2. Coresh, J., Selvin, E., Stevens, L. A., Manzi, J. et al., Prevalence of chronic kidney disease in the United States. J. Am. Med. Assoc. 2007, 298, 2038-2047.
3. Fioretto, P., Mauer, M., Histopathology of diabetic nephropathy. Semin. Nephrol. 2007, 27, 195-207.
4. Yilmaz, S., Isik, I., Afrouzian, M., Monroy, M. et al., Evaluating the accuracy of functional biomarkers for detecting histological changes in chronic allograft nephropathy. Transpl. Int. 2007, 20, 608-615.
5. Eddy, A. A., Molecular basis of renal fibrosis. Pediatr. Nephrol. 2000, 15, 290-301.
6. Fogo, A. B., Mechanisms of progression of chronic kidney disease. Pediatr. Nephrol. 2007, 22, 2011-2022.
7. Klahr, S., Morrissey, J., Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal. Physiol. 2002, 283, F861-F875.
8. Meguid El Nahas, A., Bello, A. K., Chronic kidney disease: the global challenge. Lancet 2005, 365, 331-340.
9. Merchant, M. L., Perkins, B. A., Boratyn, G. M., Ficociello, L. H. et al., Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J. Am. Soc. Nephrol. 2009, 20, 2065-2074.
10. Rossing, K., Mischak, H., Dakna, M., Zurbig, P. et al., Urinary proteomics in diabetes and CKD. J. Am. Soc. Nephrol. 2008, 19, 1283-1290.
11. Jain, S., Rajput, A., Kumar, Y., Uppuluri, N. et al., Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J. Assoc. Physicians India 2005, 53, 513-520.
12. Rao, P. V., Lu, X., Standley, M., Pattee, P. et al., Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007, 30, 629-637.
13. Sharma, K., Lee, S., Han, S., Francos, B. et al., Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005, 5, 2648-2655.
14. Varghese, S. A., Powell, T. B., Budisavljevic, M. N., Oates, J. C. et al., Urine biomarkers predict the cause of glomerular disease. J. Am. Soc. Nephrol. 2007, 18, 913-922.
15. Thongboonkerd, V., Barati, M. T., McLeish, K. R., Benarafa, C. et al., Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J. Am. Soc. Nephrol. 2004, 15, 650-662.
16. Grande, M. T., Lopez-Novoa, J. M., Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat. Rev. Nephrol. 2009, 5, 319-328.
17. Gong, D., Chen, X., Middleditch, M., Huang, L. et al., Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats. Proteomics 2009, 9, 4309-4320.
18. Kalfa, T. A., Thull, J. D., Butkowski, R. J., Charonis, A. S., Tubulointerstitial nephritis antigen interacts with laminin and type IV collagen and promotes cell adhesion. J. Biol. Chem. 1994, 269, 1654-1659.
19. Morita, H., Yoshimura, A., Inui, K., Ideura, T. et al., Heparan sulfate of perlecan is involved in glomerular filtration. J. Am. Soc. Nephrol. 2005, 16, 1703-1710.
20. Thomas, D. B., Focal segmental glomerulosclerosis: a morphologic diagnosis in evolution. Arch. Pathol. Lab. Med. 2009, 133, 217-223.
21. D'Agati, V. D., Fogo, A. B., Bruijn, J. A., Jennette, J. C., Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am. J. Kidney Dis. 2004, 43, 368-382.
22. Smeets, B., Dijkman, H. B., Wetzels, J. F., Steenbergen, E. J., Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells? J. Pathol. 2006, 210, 263-272.
23. Xu, B. J., Shyr, Y., Liang, X., Ma, L. J. et al., Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J. Am. Soc. Nephrol. 2005, 16, 2967-2975.
24. Shui, H. A., Huang, T. H., Ka, S. M., Chen, P. H. et al., Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2008, 23, 176-185.
25. Regoli, D., Barabe, J., Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 1980, 32, 1-46.
26. Lund, L. R., Green, K. A., Stoop, A. A., Ploug, M. et al., Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J. 2006, 25, 2686-2697.
27. Riad, A., Zhuo, J. L., Schultheiss, H. P., Tschope, C., The role of the renal kallikrein-kinin system in diabetic nephropathy. Curr. Opin. Nephrol. Hypertens. 2007, 16, 22-26.
28. Kypreou, K. P., Kavvadas, P., Karamessinis, P., Peroulis, M. et al., Altered expression of calreticulin during the development of fibrosis. Proteomics 2008, 8, 2407-2419.
29. Meier-Kriesche, H. U., Schold, J. D., Kaplan, B., Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am. J. Transplant. 2004, 4, 1289-1295.
30. Reuter, S., Reiermann, S., Worner, R., Schroter, R. et al., IF/TA-related metabolic changes - proteome analysis of rat renal allografts. Nephrol. Dial. Transplant. 2010, 25, 2492-2501.
31. Banon-Maneus, E., Diekmann, F., Carrascal, M., Quintana, L. F. et al., Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers. Transplantation 2010, 89, 548-558.
32. Nakorchevsky, A., Hewel, J. A., Kurian, S. M., Mondala, T. S. et al., Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J. Am. Soc. Nephrol. 2010, 21, 362-373.
33. Oikonomou, N., Thanasopoulou, A., Tzouvelekis, A., Harokopos, V. et al., Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis. Thorax 2009, 64, 467-475.
34. Li, G. H., Shi, Y., Chen, Y., Sun, M. et al., Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis. Circ. Res. 2009, 104, 896-904.
35. Schmitt, R., Marlier, A., Cantley, L. G., Zag expression during aging suppresses proliferation after kidney injury. J. Am. Soc. Nephrol. 2008, 19, 2375-2383.
36. Van Duyn Graham, L., Sweetwyne, M. T., Pallero, M. A., Murphy-Ullrich, J. E., Intracellular calreticulin regulates multiple steps in fibrillar collagen expression, trafficking, and processing into the extracellular matrix. J. Biol. Chem. 2010, 285, 7067-7078.
37. Yu, H., Konigshoff, M., Jayachandran, A., Handley, D. et al., Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis. FASEB J. 2008, 22, 1778-1789.
38. Van Rossen, E., Vander Borght, S., van Grunsven, L. A., Reynaert, H. et al., Vinculin and cellular retinol-binding protein-1 are markers for quiescent and activated hepatic stellate cells in formalin-fixed paraffin embedded human liver. Histochem. Cell Biol. 2009, 131, 313-325.
39. Coppinger, J. A., Cagney, G., Toomey, S., Kislinger, T. et al., Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103, 2096-2104.
40. Fietta, A., Bardoni, A., Salvini, R., Passadore, I. et al., Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Arthritis Res. Ther. 2006, 8, R160.
41. Schanstra, J. P., Neau, E., Drogoz, P., Arevalo Gomez, M. A. et al., In vivo bradykinin B2 receptor activation reduces renal fibrosis. J. Clin. Invest. 2002, 110, 371-379.
42. Klein, J., Gonzalez, J., Decramer, S., Bandin, F. et al., Blockade of the Kinin B1 Receptor Ameloriates Glomerulonephritis. J. Am. Soc. Nephrol. 2010, 21, 1157-1164.
43. Klein, J., Gonzalez, J., Duchene, J., Esposito, L. et al., Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy. FASEB J. 2009, 23, 134-142.
44. Bhavnani, S. K., Eichinger, F., Martini, S., Saxman, P. et al., Network analysis of genes regulated in renal diseases: implications for a molecular-based classification. Biomed. Chromatogr. Bioinform. 2009, 10, S3.
45. Hardesty, W. M., Caprioli, R. M., In situ molecular imaging of proteins in tissues using mass spectrometry. Anal. Bioanal. Chem. 2008, 391, 899-903.
46. Walch, A., Rauser, S., Deininger, S. O., Hofler, H., MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem. Cell Biol. 2008, 130, 421-434.